ArticleBMJ open2020

Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia.

Mario Muñoz Builes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.